by EmpathiCSubstanceS | May 23, 2019 | Alcoholism
A newly published study examining the use of psychedelics in non-clinical settings to treat alcoholism is suggesting a great number of individuals see a reduction in problematic alcohol consumption following strong doses of LSD or psilocybin. The research supplements...
by EmpathiCSubstanceS | Mar 19, 2019 | Depression
A new survey into the anti-depressant qualities of a short-acting psychedelic has reported extraordinarily positive improvements in well-being. The research, led by a team from Johns Hopkins University, suggests the brief duration of action seen in the drug 5-MeO-DMT...
by EmpathiCSubstanceS | Feb 13, 2019 | Depression
A new nasal spray for depression, utilizing a novel drug called esketamine, has passed the last step on its way to final FDA approval. An advisory panel to the Food and Drug Administration (FDA) voted in favor of the new drug’s risk/benefit profile meaning the...
by EmpathiCSubstanceS | Feb 13, 2019 | Depression
The active ingredients of ketamine, a popular club drug, show promise in battling deep despair. In a move that may clear the way for the first new treatment in years for depression, an expert panel recommended on Tuesday that federal regulators approve a nasal spray...
by EmpathiCSubstanceS | Feb 8, 2019 | Kambo
Trying to figure out what to put in our bodies to make them healthier is a full-fledged American pastime, which is why writer and journalist Michael Pollan has emerged as a beloved nutritional explorer. Pollan, the author of In Defense of Food and The Omnivore’s...
